The Rockefeller family's venture firm, formed in 1969, which invests in technology and healthcare companies from its Palo Alto and New York offices. Its website could not be read without JavaScript.
Venrock, a portmanteau of Venture and Rockefeller, was formed in 1969 to build on the Rockefeller family's venture investing and is headquartered in Palo Alto, California (Wikipedia). It invests in early-stage technology and healthcare companies, including biotechnology and healthcare IT, and has a long record of oncology investments. Every page fetched on venrock.com (home, portfolio, companies) returned only 'You need to enable JavaScript to run this app', so the firm's own description of its strategy and its named oncology portfolio companies could not be confirmed from a primary source.
| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Adcendo Copenhagen, DK | Growth stage | biotech | Sarcomas (soft tissue, bone, GIST) | Series C 2026, $75M |
| Enliven Therapeutics Boulder, CO, US | Public | biotech | Non-small-cell lung cancer | Crossover 2023, $165M |
| Mythic Therapeutics Waltham, MA, US | Wound down | biotech | Non-small-cell lung cancer | Series B 2021, $103M |
Shares Mythic Therapeutics and the tag vc.
Shares Enliven Therapeutics and the tag vc.
Shares Adcendo and the tag vc.
Shares Enliven Therapeutics, Adcendo and the tag vc.
Shares Adcendo and the tag vc.
Shares Mythic Therapeutics and the tag vc.
Shares Adcendo and the tag vc.
Shares Adcendo and the tag vc.